Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma

J Clin Oncol. 2016 Apr 20;34(12):e110-6. doi: 10.1200/JCO.2013.50.9471. Epub 2014 Oct 27.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antigens, CD20 / immunology
  • Antineoplastic Agents / therapeutic use*
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology
  • Biopsy
  • Disease Progression
  • Fatal Outcome
  • Female
  • Flow Cytometry
  • Humans
  • Lymphocytes, Tumor-Infiltrating / drug effects*
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / pathology
  • Lymphoma, T-Cell, Cutaneous / drug therapy*
  • Lymphoma, T-Cell, Cutaneous / immunology
  • Lymphoma, T-Cell, Cutaneous / pathology
  • Molecular Targeted Therapy
  • Neoplasm Staging
  • Remission Induction
  • Rituximab / therapeutic use*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / immunology
  • Skin Neoplasms / pathology
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antigens, CD20
  • Antineoplastic Agents
  • Rituximab